| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Barney S. Graham | Q89108863 |
| P2093 | author name string | Peter L Collins | |
| P2860 | cites work | Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein | Q24531958 |
| Pathogen recognition and innate immunity | Q27861084 | ||
| The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses. | Q30306426 | ||
| Detection of IgA and IgG but not IgE antibody to respiratory syncytial virus in nasal washes and sera from infants with wheezing | Q30306970 | ||
| Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract | Q30308521 | ||
| The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein | Q30440686 | ||
| Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection | Q30442832 | ||
| Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines | Q33177627 | ||
| Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus | Q33284309 | ||
| Surfactant protein B polymorphisms are associated with severe respiratory syncytial virus infection, but not with asthma | Q33284455 | ||
| Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines | Q33755013 | ||
| Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge | Q33783066 | ||
| Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. | Q33785124 | ||
| Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection | Q33787265 | ||
| Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity | Q33788724 | ||
| Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges | Q43800279 | ||
| Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus | Q43852460 | ||
| Natural evolution of a human virus-specific antibody gene repertoire by somatic hypermutation requires both hotspot-directed and randomly-directed processes | Q43866719 | ||
| Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection | Q43977167 | ||
| Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults | Q43979004 | ||
| Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus | Q44072444 | ||
| Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells | Q44237000 | ||
| Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy | Q44286818 | ||
| Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus | Q44354620 | ||
| Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness | Q44526388 | ||
| Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing | Q45402693 | ||
| Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection | Q45404243 | ||
| CD14 -550 C/T, which is related to the serum level of soluble CD14, is associated with the development of respiratory syncytial virus bronchiolitis in the Japanese population | Q45404518 | ||
| Common human Toll-like receptor 4 polymorphisms--role in susceptibility to respiratory syncytial virus infection and functional immunological relevance | Q45404884 | ||
| Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses | Q45406272 | ||
| Serum antibody decay in adults following natural respiratory syncytial virus infection | Q45411871 | ||
| Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections | Q45416549 | ||
| T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis. | Q45417228 | ||
| Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. | Q45420150 | ||
| Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells | Q45423182 | ||
| Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response | Q45423464 | ||
| Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection | Q45469098 | ||
| Respiratory syncytial virus load predicts disease severity in previously healthy infants | Q45470278 | ||
| Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. | Q45496193 | ||
| Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections | Q45504067 | ||
| Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants | Q45504141 | ||
| Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. | Q45556830 | ||
| Quantitative effects of palivizumab and donor-derived T cells on chronic respiratory syncytial virus infection, lung disease, and fusion glycoprotein amino acid sequences in a patient before and after bone marrow transplantation | Q45601177 | ||
| Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. | Q45627167 | ||
| Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease | Q45640302 | ||
| The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus | Q45658652 | ||
| Latency and persistence of respiratory syncytial virus despite T cell immunity | Q45697249 | ||
| Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection | Q45700396 | ||
| An outbreak of febrile illness and pneumonia associated with respiratory syncytial virus infection | Q45711711 | ||
| Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates | Q45722531 | ||
| A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants | Q45723079 | ||
| Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis | Q45723418 | ||
| Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells | Q45723895 | ||
| Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy | Q45729843 | ||
| Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs | Q45731795 | ||
| Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin | Q45732357 | ||
| Cytokines in severe respiratory syncytial virus bronchiolitis | Q45732609 | ||
| Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus | Q45733068 | ||
| The role of IFN in respiratory syncytial virus pathogenesis | Q45733409 | ||
| Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine | Q45734744 | ||
| Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis | Q45736349 | ||
| Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus | Q45739890 | ||
| Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity | Q45740483 | ||
| Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group | Q45749177 | ||
| Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein | Q45752849 | ||
| CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection | Q45757956 | ||
| Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. | Q45760779 | ||
| Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response | Q45761593 | ||
| Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children | Q45774337 | ||
| The Development of Respiratory Syncytial Virus-Specific IgE and the Release of Histamine in Nasopharyngeal Secretions after Infection | Q45805502 | ||
| Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus | Q45821276 | ||
| Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection | Q45843876 | ||
| Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages | Q45847060 | ||
| Immunity to and frequency of reinfection with respiratory syncytial virus | Q45853042 | ||
| Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G | Q45866218 | ||
| Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children | Q45888997 | ||
| Suppression of pattern-recognition receptor TLR4 sensing does not alter lung responses to pneumovirus infection. | Q47643044 | ||
| Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody repertoire compared with CD5- B cells | Q48088390 | ||
| Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. | Q51664545 | ||
| Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. | Q54374782 | ||
| IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis | Q72999006 | ||
| Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile | Q74557509 | ||
| Haplotypes of surfactant protein C are associated with common paediatric lung diseases | Q79377130 | ||
| Neonatal adaptive immunity comes of age | Q80270958 | ||
| Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. | Q33815697 | ||
| The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin | Q33863111 | ||
| Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness | Q33883942 | ||
| Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion | Q33934074 | ||
| Respiratory syncytial virus and parainfluenza virus | Q33952428 | ||
| Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus | Q34123210 | ||
| Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV. | Q34151000 | ||
| Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice | Q34199969 | ||
| The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo | Q34340452 | ||
| Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin | Q34342030 | ||
| Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology | Q34364942 | ||
| Respiratory syncytial virus infection in elderly and high-risk adults | Q34414401 | ||
| Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses | Q34486238 | ||
| The pathogenesis of respiratory syncytial virus disease in childhood | Q34628933 | ||
| Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus | Q34647754 | ||
| The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes | Q34651258 | ||
| Respiratory syncytial virus in healthy adults: the cost of a cold | Q35119781 | ||
| Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus | Q35222083 | ||
| Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. | Q35274231 | ||
| Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity | Q35548189 | ||
| Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection | Q35582849 | ||
| The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription | Q35645905 | ||
| Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity | Q35766589 | ||
| Inhibition of airway Na+ transport by respiratory syncytial virus | Q35785372 | ||
| Function of the respiratory syncytial virus small hydrophobic protein | Q35947557 | ||
| Identification of a novel virulence factor in recombinant pneumonia virus of mice | Q35948067 | ||
| Effects of viral respiratory infections on lung development and childhood asthma | Q36086948 | ||
| Heterogeneity of the association between lower respiratory illness in infancy and subsequent asthma | Q36237054 | ||
| New generation live vaccines against human respiratory syncytial virus designed by reverse genetics | Q36237057 | ||
| Palivizumab in the prophylaxis of respiratory syncytial virus infection | Q36278040 | ||
| Viral infections, cytokine dysregulation and the origins of childhood asthma and allergic diseases | Q36353658 | ||
| Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood | Q36371040 | ||
| A role for immune complexes in enhanced respiratory syncytial virus disease | Q36371267 | ||
| The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children | Q36408344 | ||
| Unravelling the complexities of respiratory syncytial virus RNA synthesis. | Q36499709 | ||
| Respiratory syncytial virus infections: recent prospects for control | Q36522190 | ||
| Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. | Q36626174 | ||
| Rhinovirus-associated hospitalizations in young children | Q36735531 | ||
| Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus | Q36871183 | ||
| Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. | Q36888695 | ||
| Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease | Q37144420 | ||
| Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine | Q37208256 | ||
| TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease | Q37364154 | ||
| Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium | Q37743793 | ||
| Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children | Q38430750 | ||
| The histopathology of fatal untreated human respiratory syncytial virus infection | Q38435017 | ||
| Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses | Q39272631 | ||
| Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser(215) and is without effe | Q39595915 | ||
| Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness | Q39640529 | ||
| Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact | Q39682220 | ||
| Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network | Q39702029 | ||
| Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication | Q39740579 | ||
| Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins | Q39789324 | ||
| The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons | Q40038247 | ||
| Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity | Q40119503 | ||
| Coupled translation of the second open reading frame of M2 mRNA is sequence dependent and differs significantly within the subfamily Pneumovirinae. | Q40128662 | ||
| Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections | Q40146611 | ||
| Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase | Q40179439 | ||
| Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth | Q40199774 | ||
| Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells | Q40208138 | ||
| The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection. | Q40432320 | ||
| Respiratory syncytial virus infections in previously healthy working adults | Q40597674 | ||
| Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. | Q40625076 | ||
| Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity | Q40708973 | ||
| Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo | Q40771213 | ||
| Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines | Q40779398 | ||
| Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies | Q40877469 | ||
| Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation | Q40951359 | ||
| Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children | Q41077230 | ||
| Experimental respiratory syncytial virus infection of four species of primates | Q41378865 | ||
| Membrane orientation and oligomerization of the small hydrophobic protein of human respiratory syncytial virus | Q41544670 | ||
| Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein | Q41625980 | ||
| Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus | Q42106072 | ||
| Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus | Q42723106 | ||
| Modeling the structure of the respiratory syncytial virus small hydrophobic protein by silent-mutation analysis of global searching molecular dynamics | Q43205497 | ||
| A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants | Q43479188 | ||
| Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection | Q43672387 | ||
| CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein | Q43690717 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| respiratory syncytial virus | Q1052913 | ||
| modulation by virus of host process | Q14818042 | ||
| modulation by host of viral process | Q22244941 | ||
| P304 | page(s) | 2040-2055 | |
| P577 | publication date | 2007-10-10 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Viral and host factors in human respiratory syncytial virus pathogenesis | |
| P478 | volume | 82 |
| Q43661405 | 1H, 13C, and 15N resonance assignment of the central domain of hRSV transcription antitermination factor M2-1. |
| Q38983251 | A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza |
| Q48506169 | A comparison of RSV and influenza in vitro kinetic parameters reveals differences in infecting time |
| Q34634867 | A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection |
| Q34242499 | A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate |
| Q33929583 | A molecular epidemiological study of respiratory viruses detected in Japanese children with acute wheezing illness |
| Q28258798 | A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye |
| Q61805621 | A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold |
| Q33690612 | A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5). |
| Q35076769 | A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression |
| Q38406868 | A sensitive real-time PCR for detection and subgrouping of human respiratory syncytial virus |
| Q34626385 | A systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus |
| Q94489294 | A three-dimensional A549 cell culture model to study respiratory syncytial virus infections |
| Q39027049 | Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection |
| Q38130514 | Advances in and the potential of vaccines for respiratory syncytial virus |
| Q92746872 | Aims, Study Design, and Enrollment Results From the Assessing Predictors of Infant Respiratory Syncytial Virus Effects and Severity Study |
| Q60046434 | Annexin A2 in Virus Infection |
| Q45364177 | Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children. |
| Q36106575 | Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice |
| Q40216566 | Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein |
| Q33811236 | Antiviral activity of ginseng extract against respiratory syncytial virus infection |
| Q39289483 | Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus |
| Q27755387 | Approved Antiviral Drugs over the Past 50 Years |
| Q42781916 | Are we too passive in our attempts to prevent respiratory syncytial virus infection in Northern Canada? |
| Q34457791 | Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins |
| Q39061469 | Atomic force microscopic investigation of respiratory syncytial virus infection in HEp-2 cells. |
| Q34583420 | Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization |
| Q36957257 | Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines |
| Q36558310 | Atypical Presentations of Respiratory Syncytial Virus Infection: Case Series |
| Q30431134 | Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus |
| Q37262708 | Autophagy-inducing protein beclin-1 in dendritic cells regulates CD4 T cell responses and disease severity during respiratory syncytial virus infection |
| Q35872028 | Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma |
| Q38257914 | Benzotriazole: An overview on its versatile biological behavior |
| Q57174667 | Biochemical characterization of the small hydrophobic protein of avian metapneumovirus |
| Q35772162 | Biomarkers of Host Response Predict Primary End-Point Radiological Pneumonia in Tanzanian Children with Clinical Pneumonia: A Prospective Cohort Study |
| Q37945196 | Buying time-the immune system determinants of the incubation period to respiratory viruses |
| Q34055489 | CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection |
| Q35543920 | Caspase-1 independent viral clearance and adaptive immunity against mucosal respiratory syncytial virus infection |
| Q36977881 | Cell-mediated immune responses to respiratory syncytial virus infection: magnitude, kinetics, and correlates with morbidity and age |
| Q47137183 | Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion Proteins |
| Q52339069 | Central Role of the NFκB Pathway in the Scgb1a1-Expressing Epithelium in Mediating Respiratory Syncytial Virus-induced Airway Inflammation. |
| Q35185596 | Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection |
| Q37002523 | Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV |
| Q37192233 | Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model |
| Q39402884 | Cimicifuga foetida L. inhibited human respiratory syncytial virus in HEp-2 and A549 cell lines |
| Q33988327 | Circulating strains of human respiratory syncytial virus in central and south America. |
| Q37368062 | Codon stabilization analysis of the "248" temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates |
| Q42208207 | Comparison of virological profiles of respiratory syncytial virus and rhinovirus in acute lower tract respiratory infections in very young Chilean infants, according to their clinical outcome |
| Q40959795 | Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells |
| Q30301182 | Control of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection |
| Q36238328 | Cross-immunity between strains explains the dynamical pattern of paramyxoviruses |
| Q64068030 | Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus |
| Q45362021 | DP2 (CRTh2) antagonism reduces ocular inflammation induced by allergen challenge and respiratory syncytial virus |
| Q37099834 | Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease |
| Q39139404 | Detection of airborne respiratory syncytial virus in a pediatric acute care clinic |
| Q30411070 | Determining the breadth of the respiratory syncytial virus-specific T cell response |
| Q37713960 | Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model |
| Q61817658 | Differential Role of Anti-Viral Sensing Pathway for the Production of Type I Interferon β in Dendritic Cells and Macrophages Against Respiratory Syncytial Virus A2 Strain Infection |
| Q35559707 | Dimerization of matrix protein is required for budding of respiratory syncytial virus |
| Q42738805 | Direct visualization of the small hydrophobic protein of human respiratory syncytial virus reveals the structural basis for membrane permeability |
| Q43734454 | Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community. |
| Q28082841 | Disease-promoting effects of type I interferons in viral, bacterial, and coinfections |
| Q36432662 | Diversity and adaptation of human respiratory syncytial virus genotypes circulating in two distinct communities: public hospital and day care center |
| Q41417466 | Echinacea reduces the risk of recurrent respiratory tract infections and complications: a meta-analysis of randomized controlled trials |
| Q33881536 | Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection |
| Q33760691 | Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells |
| Q39328333 | Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles. |
| Q37502477 | Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico |
| Q33799416 | Epitope mapping and kinetics of CD4 T cell immunity to pneumonia virus of mice in the C57BL/6 strain. |
| Q45264827 | Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. |
| Q38952128 | Evidence of respiratory syncytial virus and parainfluenza-3 virus in Mexican sheep |
| Q35260501 | Exploratory Spatial Analysis of in vitro Respiratory Syncytial Virus Co-infections |
| Q59356493 | Fatal pulmonary infection with respiratory syncytial virus in an immunocompromised adult patient: A case report |
| Q26823772 | Ferret models of viral pathogenesis |
| Q34072674 | Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection |
| Q46243326 | Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus |
| Q37213863 | Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis |
| Q47549880 | Genetic diversity of human respiratory syncytial virus circulating among children in Ibadan, Nigeria |
| Q34438559 | Genetic immunization in the lung induces potent local and systemic immune responses |
| Q37690464 | Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation |
| Q41448272 | Genetic variability in G2 and F2 region between biological clones of human respiratory syncytial virus with or without host immune selection pressure |
| Q34440116 | Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses |
| Q24202303 | Glucocorticoids for acute viral bronchiolitis in infants and young children |
| Q24234702 | Glucocorticoids for acute viral bronchiolitis in infants and young children |
| Q47555012 | Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses. |
| Q54231427 | Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis. |
| Q34057989 | Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures. |
| Q90401234 | Host Components Contributing to Respiratory Syncytial Virus Pathogenesis |
| Q27335061 | Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein |
| Q28067634 | Host cytoskeleton in respiratory syncytial virus assembly and budding |
| Q37415531 | Host-pathogen interactions during coronavirus infection of primary alveolar epithelial cells |
| Q37348134 | Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV. |
| Q40590069 | Human Respiratory Syncytial Virus: Infection and Pathology. |
| Q59359632 | Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches |
| Q36694038 | ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation. |
| Q28245563 | Identification of nucleolin as a cellular receptor for human respiratory syncytial virus |
| Q36730754 | Imaging viral RNA using multiply labeled tetravalent RNA imaging probes in live cells |
| Q37767587 | Immunity and immunopathology to viruses: what decides the outcome? |
| Q34264615 | Immunity to RSV in Early-Life. |
| Q34247261 | Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus |
| Q39822523 | Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses |
| Q35625850 | Immunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus. |
| Q34043293 | Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse |
| Q90681995 | Impact of Respiratory Syncytial Virus Infection on the Host Cell: Implications for Antiviral Strategies |
| Q90475117 | Improving immunological insights into the ferret model of human viral infectious disease |
| Q36913291 | Induction of DNA double-strand breaks and cellular senescence by human respiratory syncytial virus. |
| Q37158039 | Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3 |
| Q38670386 | Influence of weather on incidence of bronchiolitis in Australia and New Zealand. |
| Q97902342 | Inhibitory effect of PIK-24 on respiratory syncytial virus entry by blocking phosphatidylinositol-3 kinase signaling |
| Q34180049 | Innate immune recognition of respiratory syncytial virus infection |
| Q59355977 | Interactive effects of age and respiratory virus on severe lower respiratory infection |
| Q34991154 | Interactome analysis of the human respiratory syncytial virus RNA polymerase complex identifies protein chaperones as important cofactors that promote L-protein stability and RNA synthesis |
| Q33769399 | Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells |
| Q49787495 | Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients |
| Q96680272 | Interleukin-22 Inhibits Respiratory Syncytial Virus Production by Blocking Virus-Mediated Subversion of Cellular Autophagy |
| Q40076730 | Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus |
| Q36878963 | Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach |
| Q35862041 | Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants |
| Q93105055 | Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus |
| Q26830726 | Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments |
| Q33812212 | Live attenuated B. pertussis BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1/Th17 responses |
| Q39794677 | Local evolutionary patterns of human respiratory syncytial virus derived from whole-genome sequencing |
| Q33951970 | Low CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus and human metapneumovirus |
| Q47238680 | Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection. |
| Q34059404 | Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory |
| Q40061831 | Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity |
| Q27022693 | Modulation of host adaptive immunity by hRSV proteins |
| Q34755309 | Molecular epidemiology and phylodynamics of the human respiratory syncytial virus fusion protein in northern Taiwan |
| Q35831296 | Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection |
| Q35826605 | Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection |
| Q92266520 | Neutrophil recruitment and activation are differentially dependent on MyD88/TRIF and MAVS signaling during RSV infection |
| Q28115807 | New host factors important for respiratory syncytial virus (RSV) replication revealed by a novel microfluidics screen for interactors of matrix (M) protein |
| Q33558475 | Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology |
| Q36845814 | Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells |
| Q30385012 | Novel insights into human respiratory syncytial virus-host factor interactions through integrated proteomics and transcriptomics analysis |
| Q52574400 | Osteopontin plays a pivotal role in increasing severity of respiratory syncytial virus infection. |
| Q41923937 | Oxysophocarpine inhibits lung injury induced by respiratory syncytial virus |
| Q92578314 | PD-1 of Sigmodon hispidus: Gene identification, characterization and preliminary evaluation of expression in inactivated RSV vaccine-induced enhanced respiratory disease |
| Q35535626 | Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge |
| Q37002647 | Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection |
| Q92527882 | Plasmacytoid Dendritic Cells Contribute to the Production of IFN-β via TLR7-MyD88-Dependent Pathway and CTL Priming during Respiratory Syncytial Virus Infection |
| Q34502529 | Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity |
| Q58110816 | Postviral atopic airway disease: pathogenesis and potential avenues for intervention |
| Q98735527 | Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection |
| Q37841269 | Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention |
| Q33813095 | Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus |
| Q35566601 | Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years |
| Q38671927 | Prolonged viral replication and longitudinal viral dynamic differences among respiratory syncytial virus (RSV) infected infants. |
| Q37721415 | Prospects for defined epitope vaccines for respiratory syncytial virus |
| Q36739674 | Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin |
| Q34542687 | Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein |
| Q34320755 | Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus |
| Q39626990 | Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus subgroup B using SILAC coupled to LC-MS/MS. |
| Q42215606 | Rapid replacement of human respiratory syncytial virus A with the ON1 genotype having 72 nucleotide duplication in G gene |
| Q34261898 | Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase |
| Q37412509 | Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus. |
| Q38617302 | Recent advances in the development of subunit-based RSV vaccines. |
| Q33840252 | Reduced Dicer expression in the cord blood of infants admitted with severe respiratory syncytial virus disease |
| Q39629562 | Reduced innate immune response, apoptosis, and virus release in cells cured of respiratory syncytial virus persistent infection. |
| Q37053256 | Regulation of STAT signaling in mouse bone marrow derived dendritic cells by respiratory syncytial virus. |
| Q35765491 | Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. |
| Q37252618 | Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice |
| Q37127882 | Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities |
| Q58780345 | Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization |
| Q40760956 | Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology |
| Q59358484 | Respiratory Syncytial Virus Hospitalizations among U.S. Preterm Infants Compared with Term Infants Before and After the 2014 American Academy of Pediatrics Guidance on Immunoprophylaxis: 2012-2016 |
| Q103825959 | Respiratory Syncytial Virus Infection Reduces Kynurenic Acid Production and Reverses Th17/Treg Balance by Modulating Indoleamine 2,3-Dioxygenase (IDO) Molecules in Plasmacytoid Dendritic Cells |
| Q41232947 | Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells |
| Q90280265 | Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005-2017 |
| Q26748983 | Respiratory Syncytial Virus and Cellular Stress Responses: Impact on Replication and Physiopathology |
| Q36151400 | Respiratory Syncytial Virus-Infected Mesenchymal Stem Cells Regulate Immunity via Interferon Beta and Indoleamine-2,3-Dioxygenase |
| Q38694691 | Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection. |
| Q28540852 | Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation |
| Q91361642 | Respiratory syncytial virus entry and how to block it |
| Q42978263 | Respiratory syncytial virus genotypes NA1, ON1, and BA9 are prevalent in Thailand, 2012-2015. |
| Q30425776 | Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2. |
| Q39525784 | Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants |
| Q37239031 | Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin |
| Q40054901 | Respiratory syncytial virus infection of newborn CX3CR1-deficient mice induces a pathogenic pulmonary innate immune response |
| Q39897567 | Respiratory syncytial virus inhibits lung epithelial Na+ channels by up-regulating inducible nitric-oxide synthase. |
| Q33886159 | Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response |
| Q38076133 | Respiratory syncytial virus persistence in macrophages alters the profile of cellular gene expression |
| Q36946801 | Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model |
| Q56893551 | Respiratory syncytial virus vaccine development |
| Q84854616 | Respiratory syncytial virus vaccine development |
| Q38098094 | Respiratory syncytial virus--a comprehensive review |
| Q57798434 | Respiratory syncytial virus-associated seizures in Korean children, 2011-2016. |
| Q38656562 | Respiratory syncytial virus: a systematic scientometric analysis of the global publication output and the gender distribution of publishing authors |
| Q38079432 | Respiratory syncytial virus: current progress in vaccine development |
| Q33591243 | Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology |
| Q36672339 | Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand |
| Q36650501 | Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome |
| Q40749296 | Robust Cytokine and Chemokine Response in Nasopharyngeal Secretions: Association With Decreased Severity in Children With Physician Diagnosed Bronchiolitis |
| Q34175747 | Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1 |
| Q34271670 | Roles of the respiratory syncytial virus trailer region: effects of mutations on genome production and stress granule formation |
| Q42173061 | Scop3D: three-dimensional visualization of sequence conservation |
| Q35667184 | Sendai virus-based RSV vaccine protects African green monkeys from RSV infection |
| Q33724997 | Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model |
| Q59794692 | Sequence Analysis of the Fusion Protein Gene of Human Respiratory Syncytial Virus Circulating in China from 2003 to 2014 |
| Q30834597 | Single- and multiple viral respiratory infections in children: disease and management cannot be related to a specific pathogen |
| Q58566365 | State of the Art in Respiratory Syncytial Virus Drug Discovery and Development |
| Q116166980 | Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2 |
| Q37174419 | Suppression of IRG-1 Reduces Inflammatory Cell Infiltration and Lung Injury in Respiratory Syncytial Virus Infection by Reducing Production of Reactive Oxygen Species |
| Q89842506 | Suspension microarray-based comparison of oropharyngeal swab and bronchoalveolar lavage fluid for pathogen identification in young children hospitalized with respiratory tract infection |
| Q40309226 | Systematic Analysis of Cell-Type Differences in the Epithelial Secretome Reveals Insights into the Pathogenesis of Respiratory Syncytial Virus-Induced Lower Respiratory Tract Infections |
| Q28395374 | T cell-mediated host immune defenses in the lung |
| Q59358485 | T-Cell Responses in Adults During Natural Respiratory Syncytial Virus Infection |
| Q35101883 | The Role of RSV Infection in Asthma Initiation and Progression: Findings in a Mouse Model |
| Q33887779 | The Thr205 phosphorylation site within respiratory syncytial virus matrix (M) protein modulates M oligomerization and virus production |
| Q33535780 | The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung. |
| Q36163501 | The human respiratory syncytial virus nonstructural protein 1 regulates type I and type II interferon pathways |
| Q40522232 | The innate immune response to RSV: Advances in our understanding of critical viral and host factors. |
| Q28728377 | The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology |
| Q40933366 | The preventive effect of vaccine prophylaxis on severe respiratory syncytial virus infection: A meta-analysis. |
| Q37585325 | The regulation of type I interferon production by paramyxoviruses. |
| Q58611829 | The resistance against Trichinella spiralis infection induced by primary infection with respiratory syncytial virus |
| Q41511965 | The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies |
| Q59358526 | The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates |
| Q64286426 | The viral protein corona directs viral pathogenesis and amyloid aggregation |
| Q36947774 | Tiotropium Attenuates Virus-Induced Pulmonary Inflammation in Cigarette Smoke-Exposed Mice |
| Q57174671 | Topology and cellular localization of the small hydrophobic protein of avian metapneumovirus |
| Q40104785 | Transient Depletion of CD169+ Cells Contributes to Impaired Early Protection and Effector CD8+ T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection |
| Q38140040 | Translational sciences approach to RSV vaccine development |
| Q59356158 | Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy |
| Q64229661 | Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection |
| Q28071857 | Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome |
| Q90617438 | Viral N6-methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus |
| Q37788451 | Viral pneumonias in immunocompromised adult hosts |
| Q36723340 | Viral shedding and immune responses to respiratory syncytial virus infection in older adults |
| Q37996242 | Virus entry: old viruses, new receptors |
| Q34791209 | Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells |
| Q40409972 | Virus-like particle vaccine by intranasal vaccination elicits protective immunity against respiratory syncytial viral infection in mice |
| Q49187990 | Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell Responses. |
| Q36559764 | p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly |
| Q64129570 | siRNA-Mediated Simultaneous Regulation of the Cellular Innate Immune Response and Human Respiratory Syncytial Virus Replication. |
Search more.